Ten Capital Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Ten Capital Wealth Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$223K	Buy	3,490 +2,035	+140%	+$136K	0.06%	119
2023 Q1	$101K	Hold	1,455	–	–	0.03%	160
2022 Q4	$105K	Buy	1,455 +410	+39%	+$30.9K	0.04%	131
2022 Q3	$74K	Buy	1,045 +849	+433%	+$61.6K	0.03%	131
2022 Q2	$15K	Hold	196	–	–	0.01%	227
2022 Q1	$14K	Buy	196 +26	+15%	+$1.75K	0.01%	249
2021 Q4	$11K	Hold	170	–	–	﹤0.01%	287
2021 Q3	$10K	Hold	170	–	–	﹤0.01%	266
2021 Q2	$11K	Buy	+170	New	+$11.1K	﹤0.01%	305

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ten Capital Wealth Advisors's BMY Position: Q2 2023 in Review

Ten Capital Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 140% in Q2 2023, buying an estimated $136K and bringing the position to 3,490 shares worth $223K. The position accounts for 0.06% of the portfolio, ranked #119.

Ten Capital Wealth Advisors first reported a position in BMY in Q2 2021 and has held it in 9 quarters since. 2,481 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Ten Capital Wealth Advisors held 3,490 shares of Bristol-Myers Squibb worth $223K as of Q2 2023.
Ten Capital Wealth Advisors bought 2,035 Bristol-Myers Squibb shares in Q2 2023, an estimated $136K.
Bristol-Myers Squibb made up 0.06% of Ten Capital Wealth Advisors's portfolio in Q2 2023, its #119 holding.
Ten Capital Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 9 quarters since.
2,481 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Ten Capital Wealth Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.